Follow
Pasupathi Sundaramoorthy
Pasupathi Sundaramoorthy
Research Scientist II, Charles River Laboratory, North Carolina
No verified email
Title
Cited by
Cited by
Year
Multimodal selenium nanoshell-capped Au@mSiO2 nanoplatform for NIR-responsive chemo-photothermal therapy against metastatic breast cancer
T Ramasamy, HB Ruttala, P Sundaramoorthy, BK Poudel, YS Youn, ...
NPG Asia Materials 10 (4), 197-216, 2018
992018
Engineering of caveolae-specific self-micellizing anticancer lipid nanoparticles to enhance the chemotherapeutic efficacy of oxaliplatin in colorectal cancer cells
P Sundaramoorthy, T Ramasamy, SK Mishra, KY Jeong, CS Yong, ...
Acta Biomaterialia 42, 220-231, 2016
762016
Entrapment of curcumin into monoolein-based liquid crystalline nanoparticle dispersion for enhancement of stability and anticancer activity
R Baskaran, T Madheswaran, P Sundaramoorthy, HM Kim, BK Yoo
International journal of nanomedicine, 3119-3130, 2014
532014
Modulation of intracellular calcium levels by calcium lactate affects colon cancer cell motility through calcium-dependent calpain
P Sundaramoorthy, JJ Sim, YS Jang, SK Mishra, KY Jeong, P Mander, ...
PLoS One 10 (1), e0116984, 2015
362015
PINK1‐dependent mitophagy regulates the migration and homing of multiple myeloma cells via the MOB1B‐mediated hippo‐YAP/TAZ pathway
S Fan, T Price, W Huang, M Plue, J Warren, P Sundaramoorthy, B Paul, ...
Advanced Science 7 (5), 1900860, 2020
312020
The combination of a sphingosine kinase 2 inhibitor (ABC294640) and a Bcl‐2 inhibitor (ABT‐199) displays synergistic anti‐myeloma effects in myeloma cells without at (11; 14 …
P Sundaramoorthy, C Gasparetto, Y Kang
Cancer medicine 7 (7), 3257-3268, 2018
272018
Polyunsaturated fatty acid-based targeted nanotherapeutics to enhance the therapeutic efficacy of docetaxel
T Ramasamy, P Sundaramoorthy, HB Ruttala, Y Choi, WH Shin, JH Jeong, ...
Drug Delivery 24 (1), 1262-1272, 2017
212017
Enhanced skin permeation of 5α-reductase inhibitors entrapped into surface-modified liquid crystalline nanoparticles
T Madheswaran, R Baskaran, P Sundaramoorthy, BK Yoo
Archives of pharmacal research 38, 534-542, 2015
212015
Thioredoxin mitigates radiation-induced hematopoietic stem cell injury in mice
P Sundaramoorthy, Q Wang, Z Zheng, Y Jiao, BJ Chen, PL Doan, ...
Stem cell research & therapy 8, 1-12, 2017
192017
In Vitro Cytotoxicity and Bioavailability of Ginsenoside-Modified Nanostructured Lipid Carrier Containing Curcumin
A Vijayakumar, R Baskaran, JH Baek, P Sundaramoorthy, BK Yoo
AAPS PharmSciTech 20, 1-8, 2019
182019
Synergistically anti-metastatic effect of 5-flourouracil on colorectal cancer cells via calcium-mediated focal adhesion kinase proteolysis
M Park, P Sundaramoorthy, JJ Sim, KY Jeong, HM Kim
Anticancer research 37 (1), 103-114, 2017
172017
Novel self-micellizing anticancer lipid nanoparticles induce cell death of colorectal cancer cells
P Sundaramoorthy, R Baskaran, SK Mishra, KY Jeong, SH Oh, BK Yoo, ...
Colloids and Surfaces B: Biointerfaces 135, 793-801, 2015
172015
Calcium/calmodulin dependent protein kinase kinase 2 regulates the expansion of tumor-induced myeloid-derived suppressor cells
W Huang, Y Liu, A Luz, M Berrong, JN Meyer, Y Zou, E Swann, ...
Frontiers in Immunology 12, 754083, 2021
142021
Phase I study of opaganib, an oral sphingosine kinase 2-specific inhibitor, in relapsed and/or refractory multiple myeloma
Y Kang, P Sundaramoorthy, C Gasparetto, D Feinberg, S Fan, G Long, ...
Annals of hematology 102 (2), 369-383, 2023
62023
Thioredoxin-1 regulates self-renewal and differentiation of murine hematopoietic stem cells through p53 tumor suppressor
S Jabbar, P Mathews, X Wang, P Sundaramoorthy, E Chu, SO Piryani, ...
Experimental Hematology & Oncology 11 (1), 83, 2022
52022
Chromatin Remodeling in Patient‐Derived Colorectal Cancer Models
K Xiang, E Wang, J Mantyh, G Rupprecht, M Negrete, G Sanati, C Hsu, ...
Advanced Science, 2303379, 2022
12022
Relationship of acquired resistance of myeloma cells to bortezomib with Lyn and Src induced inhibition of PP2A and effect of treatment with the tyrosine kinase inhibitor dasatinib.
B Paul, D Feinberg, P Sundaramoorthy, JB Weinberg, Y Kang
Journal of Clinical Oncology 36 (15_suppl), 8047-8047, 2018
12018
Differential flt3 mutational status in acute myeloid leukemia predicts sensitivity to flt3 inhibitor gilteritinib in vitro and in vivo
B John, P Sundaramoorthy, E Rainbolt, A Wong, Z Ward, J Avery, S Todd, ...
Cancer Research 83 (7_Supplement), 8-8, 2023
2023
Novel autophagy inducer, a4368 improves non-alchoholic steatohepatitis in mice
HJ Jung, S Choi, ML Jin, S Pasupathi, MW Kim, JH Kang, HG Choi, ...
Journal of Hepatology 73, S457, 2020
2020
A novel autophagy inducer, AS777, ameliorates liver fibrosis via suppressing liver inflammation
S Choi, MW Kim, P Sundaramoorthy, H Jung, JH Kang, KW Jeong, ...
한국실험동물학회 학술발표대회 논문집, 146-146, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20